Literature DB >> 2386366

Quantitative study of antibiotic-induced susceptibility to Clostridium difficile enterocecitis in hamsters.

H E Larson1, S P Borriello.   

Abstract

Commonly used antibiotics were compared for their ability to induce Clostridium difficile enterocecitis and death in hamsters. Susceptibility to infection with C. difficile was measured by calculating 50% lethal doses (in CFU) for hamsters for various intervals after antibiotic treatment. Infection occurred after very small doses of C. difficile were given to hamsters treated with clindamycin, ampicillin, flucloxacillin, and cefuroxime; there was little difference between the antibiotics in the degree of susceptibility that they induced. A large difference in the duration of susceptibility was observed, however, with susceptibility being temporary following ampicillin, flucloxacillin, and cefuroxime administration but long-lived following clindamycin administration. A larger dose of ampicillin, multiple doses of ampicillin, and a combination of antibiotics had comparatively small effects on the duration of susceptibility. C. difficile growth and toxin production in in vitro suspensions of cecal contents were found to correlate closely with in vivo hamster infectivity. A persisting loss of colonization resistance following antibiotic treatment may be a type of postantibiotic effect. Although these results cannot be applied directly to humans, they suggest lines of further investigation into how antibiotics may differ in producing risks of C. difficile infection and pseudomembranous colitis in patients.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2386366      PMCID: PMC175979          DOI: 10.1128/AAC.34.7.1348

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  19 in total

Review 1.  Pseudomembranous enterocolitis: a review of its diverse forms.

Authors:  S L Gorbach; J G Bartlett
Journal:  J Infect Dis       Date:  1977-03       Impact factor: 5.226

Review 2.  Antimicrobial prophylaxis in surgery.

Authors:  A B Kaiser
Journal:  N Engl J Med       Date:  1986-10-30       Impact factor: 91.245

3.  The postantibiotic effect.

Authors:  W A Craig; B Vogelman
Journal:  Ann Intern Med       Date:  1987-06       Impact factor: 25.391

Review 4.  Clindamycin.

Authors:  A S Klainer
Journal:  Med Clin North Am       Date:  1987-11       Impact factor: 5.456

5.  Antibiotic-induced lethal enterocolitis in hamsters: studies with eleven agents and evidence to support the pathogenic role of toxin-producing Clostridia.

Authors:  J G Bartlett; T W Chang; N Moon; A B Onderdonk
Journal:  Am J Vet Res       Date:  1978-09       Impact factor: 1.156

6.  Intestinal beta-lactamase activity in ampicillin-induced, Clostridium difficile-associated ileocecitis.

Authors:  R D Rolfe; S M Finegold
Journal:  J Infect Dis       Date:  1983-02       Impact factor: 5.226

7.  Clostridium difficile and antibiotic associated diarrhoea in Sweden.

Authors:  B Aronsson; R Möllby; C E Nord
Journal:  Scand J Infect Dis Suppl       Date:  1982

8.  Clostridium difficile and the aetiology of pseudomembranous colitis.

Authors:  H E Larson; A B Price; P Honour; S P Borriello
Journal:  Lancet       Date:  1978-05-20       Impact factor: 79.321

9.  An in-vitro model of colonisation resistance to Clostridium difficile infection.

Authors:  S P Borriello; F E Barclay
Journal:  J Med Microbiol       Date:  1986-06       Impact factor: 2.472

10.  Clostridium difficile-associated diarrhea follows perioperative prophylaxis with cefoxitin.

Authors:  B S Block; L J Mercer; M A Ismail; A H Moawad
Journal:  Am J Obstet Gynecol       Date:  1985-12-15       Impact factor: 8.661

View more
  14 in total

Review 1.  Recognition and prevention of hospital-associated enteric infections in the intensive care unit.

Authors:  Linda D Bobo; Erik R Dubberke
Journal:  Crit Care Med       Date:  2010-08       Impact factor: 7.598

2.  Antibiotic-Induced Dysbiosis Predicts Mortality in an Animal Model of Clostridium difficile Infection.

Authors:  France Mentré; Jean de Gunzburg; Charles Burdet; Sakina Sayah-Jeanne; Thu Thuy Nguyen; Perrine Hugon; Frédérique Sablier-Gallis; Nathalie Saint-Lu; Tanguy Corbel; Stéphanie Ferreira; Mark Pulse; William Weiss; Antoine Andremont
Journal:  Antimicrob Agents Chemother       Date:  2018-09-24       Impact factor: 5.191

Review 3.  Models for the study of Clostridium difficile infection.

Authors:  Emma L Best; Jane Freeman; Mark H Wilcox
Journal:  Gut Microbes       Date:  2012-03-01

Review 4.  Hypervirulent strains of Clostridium difficile.

Authors:  Barry Cookson
Journal:  Postgrad Med J       Date:  2007-05       Impact factor: 2.401

5.  Immunogenicity of a Salmonella typhimurium aroA aroD vaccine expressing a nontoxic domain of Clostridium difficile toxin A.

Authors:  S J Ward; G Douce; D Figueiredo; G Dougan; B W Wren
Journal:  Infect Immun       Date:  1999-05       Impact factor: 3.441

6.  Local and systemic neutralizing antibody responses induced by intranasal immunization with the nontoxic binding domain of toxin A from Clostridium difficile.

Authors:  S J Ward; G Douce; G Dougan; B W Wren
Journal:  Infect Immun       Date:  1999-10       Impact factor: 3.441

7.  Infection of hamsters with the UK Clostridium difficile ribotype 027 outbreak strain R20291.

Authors:  Anthony M Buckley; Janice Spencer; Denise Candlish; June J Irvine; Gillian R Douce
Journal:  J Med Microbiol       Date:  2011-02-17       Impact factor: 2.472

8.  Effect of dietary antimicrobials on immune status in broiler chickens.

Authors:  K W Lee; H S Lillehoj; S H Lee; S I Jang; M S Park; D A Bautista; G D Ritter; Y H Hong; G R Siragusa; E P Lillehoj
Journal:  Asian-Australas J Anim Sci       Date:  2012-03       Impact factor: 2.509

9.  Muricholic acids inhibit Clostridium difficile spore germination and growth.

Authors:  Michael B Francis; Charlotte A Allen; Joseph A Sorg
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

10.  The protective effect of recombinant Lactococcus lactis oral vaccine on a Clostridium difficile-infected animal model.

Authors:  Xiao-qiang Yang; Ya-gang Zhao; Xue-qing Chen; Bo Jiang; Da-yong Sun
Journal:  BMC Gastroenterol       Date:  2013-07-17       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.